Paired [18F]FDOPA and [18F]FDG PET Shows Complementary Prognostic Associations at Recurrence in IDH-Wildtype Glioblastoma
- 1Service de Neurochirurgie, Hôpitaux Universitaires de Strasbourg (HUS), 67200 Strasbourg, France
- 2ICube, Université de Strasbourg/CNRS (UMR 7357), 67085 Strasbourg, France
- 3Service de Médecine Nucléaire et d’Imagerie Moléculaire, Institut Strauss, 67200 Strasbourg, France
Abstract
Background/Objectives: Prognostic PET biomarkers in glioblastoma remain mostly as a single tracer and poorly characterized at recurrence. We investigated whether paired [18F]FDOPA/[18F]FDG PET captures complementary metabolic information associated with survival in IDH-wildtype glioblastoma. Methods: Sixty-five consecutive patients underwent paired [18F]FDOPA/[18F]FDG PET/MR at baseline and/or recurrence. Survival was analyzed from baseline PET/MR (OS1, n = 36) and recurrence PET/MR (OS2, n = 55); longitudinal analyses used the paired subgroup (n = 26). FDOPA and FDG tumor masks were independently segmented within a FLAIR-derived tumor box, and metrics were extracted from tracer-specific masks, their intersection, and their union. Metrics significant in Kaplan–Meier or univariable Cox analyses were tested in adjusted Cox models. Benjamini–Hochberg false discovery rate correction was used as a sensitivity analysis for the continuous Cox screening tests. Results: In exploratory screening, prognostic associations were sparse at baseline and more prominent at recurrence. At OS2, three metrics remained independently associated with survival after adjustment: the FDOPA/FDG union-domain SUVmeanunion ratio (HR, 1.50; p = 0.0168), MTVinter (HR, 1.63; p = 0.0154), and MTVDOPA (HR, 1.58; p = 0.0191). The SUVmeanunion ratio and MTVDOPA showed limited correlation, suggesting complementary information. Their integration into IR-MTVDOPA, defined as FDOPA/FDG SUVmeanunion ratio × log(MTVDOPA), showed higher apparent OS2 discrimination (HR, 1.73; log-rank p = 0.0001; C-index, 0.730; bootstrap .632-corrected C-index, 0.684; 12-month AUC, 0.863). Conclusions: In this exploratory single-center cohort, paired [18F]FDOPA/[18F]FDG PET showed prognostic associations at recurrence. Inter-tracer intensity balance and metabolic tumor burden provided partially complementary survival information, and their exploratory integration showed higher apparent discrimination. External validation is required before clinical implementation.
Related
- Evaluating the Prognostic Significance of the H-Index and Systemic Inflammatory Parameters in IDH-Wildtype Glioblastoma Survival.
- Pretreatment Lactate Dehydrogenase-to-Albumin Ratio Identifies an Early Adverse Prognostic Profile in IDH-Wildtype Glioblastoma: A Real-World Cohort Study.
- Glioblastoma, IDH-wildtype, with spontaneous transdural and calvarial invasion: a case report and literature review
- Intracranial dose constraints in IDH-wildtype glioblastoma: a framework for context-specific application
- Early extracranial dissemination with prolonged survival in IDH-wildtype glioblastoma: case study and comprehensive literature review.
BibTeX
@article{todeschi2026paired,
title = {{Paired [18F]FDOPA and [18F]FDG PET Shows Complementary Prognostic Associations at Recurrence in IDH-Wildtype Glioblastoma}},
author = {Julien Todeschi and Julien Salvadori and Oreste Allegrini and Hélène Cebula and Caroline Bund and Izzie-Jacques Namer},
journal = {Cancers},
year = {2026},
month = oct,
doi = {10.3390/cancers18203333},
url = {https://www.mdpi.com/2072-6694/18/20/3333},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Paired [18F]FDOPA and [18F]FDG PET Shows Complementary Prognostic Associations at Recurrence in IDH-Wildtype Glioblastoma
AU - Julien Todeschi
AU - Julien Salvadori
AU - Oreste Allegrini
AU - Hélène Cebula
AU - Caroline Bund
AU - Izzie-Jacques Namer
PY - 2026
DA - 2026/10/01
JO - Cancers
DO - 10.3390/cancers18203333
UR - https://www.mdpi.com/2072-6694/18/20/3333
AB - Background/Objectives: Prognostic PET biomarkers in glioblastoma remain mostly as a single tracer and poorly characterized at recurrence. We investigated whether paired [18F]FDOPA/[18F]FDG PET captures complementary metabolic information associated with survival in IDH-wildtype glioblastoma. Methods: Sixty-five consecutive patients underwent paired [18F]FDOPA/[18F]FDG PET/MR at baseline and/or recurrence. Survival was analyzed from baseline PET/MR (OS1, n = 36) and recurrence PET/MR (OS2, n = 55); longitudinal analyses used the paired subgroup (n = 26). FDOPA and FDG tumor masks were independently segmented within a FLAIR-derived tumor box, and metrics were extracted from tracer-specific masks, their intersection, and their union. Metrics significant in Kaplan–Meier or univariable Cox analyses were tested in adjusted Cox models. Benjamini–Hochberg false discovery rate correction was used as a sensitivity analysis for the continuous Cox screening tests. Results: In exploratory screening, prognostic associations were sparse at baseline and more prominent at recurrence. At OS2, three metrics remained independently associated with survival after adjustment: the FDOPA/FDG union-domain SUVmeanunion ratio (HR, 1.50; p = 0.0168), MTVinter (HR, 1.63; p = 0.0154), and MTVDOPA (HR, 1.58; p = 0.0191). The SUVmeanunion ratio and MTVDOPA showed limited correlation, suggesting complementary information. Their integration into IR-MTVDOPA, defined as FDOPA/FDG SUVmeanunion ratio × log(MTVDOPA), showed higher apparent OS2 discrimination (HR, 1.73; log-rank p = 0.0001; C-index, 0.730; bootstrap .632-corrected C-index, 0.684; 12-month AUC, 0.863). Conclusions: In this exploratory single-center cohort, paired [18F]FDOPA/[18F]FDG PET showed prognostic associations at recurrence. Inter-tracer intensity balance and metabolic tumor burden provided partially complementary survival information, and their exploratory integration showed higher apparent discrimination. External validation is required before clinical implementation.
SN - 2072-6694
ER -